Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Right on Chaka! GO CELZ!
Good Morning CELZrs! Yesterday's popcorn was great. I think I'll make a new batch for today. Good Luck!
I agree! $.039 would look nice today! GO CELZ!
Good Morning CELZrs! Get your popcorn ready.....
Go CELZ!
From what I know, over 500,000,000 shares are locked up. NO ONE CAN GET THEM!
Go CELZ! Nice job NSX
Go CELZ! I bought today and so have my group. Not a lot, but it's good for us.
Go CELZ!!! Not going anywhere, haven't gone anywhere.
Know what you own and do your own DD. There's too much in this company to leave. I know it is low now, but I know what I have.
Anyone have any popcorn?
MMs with their games again!
Go CELZ!
Go CELZ
What a bunch of BS dropping 2.3 million on $.0078!
Just a random "Guess", it looks like someone with 6,000,000 shares had a stop loss at $.0068. Maybe they needed the $40,000+???
Go CELZ!
Looks like we're ready for take off! 747
This is what the INVESTORS KNOW about CELZ.......but don't trust me or anyone on the blog. Do you own DD please, and you too will KNOW......
The FDA does not regulate medical procedures performed by qualified and licensed doctors. CaverStem® has the only clinically proven procedure to treat Erectile Dysfunction with adult stem cells in the US. CaverStem® ONLY uses your own adult stem cells (not Embryonic stem cells) and they are not altered, manipulated or stored. Therefore, FDA does not object to these procedures.
CaverStem® has been shown to be effective even in patients who do not respond to PDE5 inhibitors, and, unlike PED5 inhibitors, CaverStem® and FemCelz is safe.
Several doctors in the US have been vetted and signed and are now OPEN and treating patients (Doctors Gershman, Said, Bieri, Liu, Narayan, Niemczyk and Sanderson). Currently you can make an appointment any of those locations along with Dr. Antonini in Rome, Italy.
Three shareholders are among the treated patients and can confirm the ease of the treatment for the patient. Testimonials will be published soon.
CELZ added physicians in Hawaii (Sanderson), California, Ohio, Texas and Tennessee (to be named soon) and CELZ will continually add the new physicians to the CaverStem® website as they come aboard. CELZ is adding approximately 5 doctors per month in the most recent two months.
To speed up new physician training due to the demand, CELZ added additional medical personnel to travel to each physicians office to train.
Due to the increased international demand and to compliment the existing relationship with Scott Shea, Thomas Bianchi has joined the company as the international sales representative. DD will tell you that interest in increasing in Europe.
Marketing Director David Brandt has been interviewing patients and is preparing customer testimonial videos.
CELZ has started treating the first patients with the FemCelz procedure for the treatment of female sexual dysfunction using stem cells from the patient's own bone marrow. Many of the existing CaverStem® affiliated physician's will also treat female patients for sexual function and we anticipate that they will be the leaders in progressing the FemCelz program. Doctors have been treating the first patients with FemCelz and additional doctors are scheduled to be trained in FemCelz procedures.
Over 50 domain names have been registered showing that MANY more doctors are being vetted or have shown interest. These includes MANY cities and states in the USA, and now we KNOW there are domains registered in Russia (PromoMed, Dr. Pushkar), Germany, France, Switzerland (Alto Uro, Dr. Bachmann) and Austria.
CELZ has begun a series of mailer and email campaigns introducing the CaverStem® procedure to licensed physicians in the areas of urology, OB/GYN, sexual function and plastic surgery. This campaign which will be expanded on a monthly basis with follow up mailers and emails and calls from our sales representatives. It's the goal to reach out to a minimum of 2500 new physicians each month by these methods. CELZ reported good replies from the January emails. Your DD will show you that more interest is building each month.
CELZ has also increased its online presence on Social Media and by placing banner advertising on websites and search engines attracting the active male. They are currently scripting television commercials which will be edited to direct patients to each physician in their area.
U.S. and international agreements have been reached for exclusive distribution rights for the FDA approved Generation 2 bone marrow harvest technology which has been used with multiple ED patients with excellent results, however Government exemptions are required for the ongoing import of the device in Russia. This is a slow and tedious process in getting approval, therefore CELZ progress has been delayed in Russia.
Your DD will show that Dr. Gershman has been performing the procedure with EXCELLENT results…Up to 90% success rate, even in difficult patients. CELZ has received positive feedback from treating physicians of a 70% to 90% efficacy in their patients. Obviously results differ depending on the age and health of the patient and cause and severity of their erectile dysfunction.
A one-year trial has concluded and will PROVE the same results and you can watch it here; https://clinicaltrials.gov/ct2/show/NCT03699943...
CELZ is working on their paper for publication. This is ongoing and in compliance with contractual obligations. Once the paper has been approved by The Journal of Translational Medicine and a publication date advised, shareholders will be updated. Additionally, CELZ has designed an electronic patient registry that is intended to include data from the clinical trial, data from treating physicians using centrifuge technology with a 30cc to 60cc bone marrow aspiration and the second generation, needle only.
Revenue has now started, CELZ is cash flowing. Additional physicians are scheduled for training, patients are being treated and revenues are being generated and increasing each month. CELZ anticipates reaching financial self-sufficiency by revenues from sales in 2019.
CELZ has Institutional Investors now, slowing dilution and providing much better terms as CELZ completes the commercialization phase. The most recent notes that were issued in 2018 were renegotiated providing cash for operations.
CELZ signed with PatientGain to redesigning the website for the anticipated HUGE volume of traffic CaverStem® and FemCelz will generate. This has generated many calls to the vetted doctors.
CMTH anticipates acquiring the Virility Centers of America brand from affiliate company Creative Medical Health, Inc. The use of the Virility Centers brand is related to male and female wellness clinics, including sexual function (CaverStem® and FemCelzTM), incontinence and infertility. This brand will compliment the CaverStem® and FemCelz brands.
CaverStem® and FemCelz are just TWO of SEVERAL patents held by CMTH.
4 NEW patents were applied for in 2018.
Gershman and Ichim have already successfully commercialized Medistem.
CaverStem®, FemCelz, StemSpine & AmnioStem have all be TRADEMARKED
CaverStem is now a REGISTERED TRADEMARK. Caverstem®
We KNOW Caverstem® + FemCelz + StemSpine + AmnioStem = NASDAQ
This is what the INVESTORS KNOW about CELZ.......but don't trust me or anyone on the blog. Do you own DD please, and you too will KNOW......
The FDA does not regulate medical procedures performed by qualified and licensed doctors. CaverStem® has the only clinically proven procedure to treat Erectile Dysfunction with adult stem cells in the US. CaverStem® ONLY uses your own adult stem cells (not Embryonic stem cells) and they are not altered, manipulated or stored. Therefore, FDA does not object to these procedures.
CaverStem® has been shown to be effective even in patients who do not respond to PDE5 inhibitors, and, unlike PED5 inhibitors, CaverStem® and FemCelz is safe.
Several doctors in the US have been vetted and signed and are now OPEN and treating patients (Doctors Gershman, Said, Bieri, Liu, Narayan, Niemczyk and Sanderson). Currently you can make an appointment any of those locations along with Dr. Antonini in Rome, Italy.
Three shareholders are among the treated patients and can confirm the ease of the treatment for the patient. Testimonials will be published soon.
CELZ added physicians in Hawaii (Sanderson), California, Ohio, Texas and Tennessee (to be named soon) and CELZ will continually add the new physicians to the CaverStem® website as they come aboard. CELZ is adding approximately 5 doctors per month in the most recent two months.
To speed up new physician training due to the demand, CELZ added additional medical personnel to travel to each physicians office to train.
Due to the increased international demand and to compliment the existing relationship with Scott Shea, Thomas Bianchi has joined the company as the international sales representative. DD will tell you that interest in increasing in Europe.
Marketing Director David Brandt has been interviewing patients and is preparing customer testimonial videos.
CELZ has started treating the first patients with the FemCelz procedure for the treatment of female sexual dysfunction using stem cells from the patient's own bone marrow. Many of the existing CaverStem® affiliated physician's will also treat female patients for sexual function and we anticipate that they will be the leaders in progressing the FemCelz program. Doctors have been treating the first patients with FemCelz and additional doctors are scheduled to be trained in FemCelz procedures.
Over 50 domain names have been registered showing that MANY more doctors are being vetted or have shown interest. These includes MANY cities and states in the USA, and now we KNOW there are domains registered in Russia (PromoMed, Dr. Pushkar), Germany, France, Switzerland (Alto Uro, Dr. Bachmann) and Austria.
CELZ has begun a series of mailer and email campaigns introducing the CaverStem® procedure to licensed physicians in the areas of urology, OB/GYN, sexual function and plastic surgery. This campaign which will be expanded on a monthly basis with follow up mailers and emails and calls from our sales representatives. It's the goal to reach out to a minimum of 2500 new physicians each month by these methods. CELZ reported good replies from the January emails. Your DD will show you that more interest is building each month.
CELZ has also increased its online presence on Social Media and by placing banner advertising on websites and search engines attracting the active male. They are currently scripting television commercials which will be edited to direct patients to each physician in their area.
U.S. and international agreements have been reached for exclusive distribution rights for the FDA approved Generation 2 bone marrow harvest technology which has been used with multiple ED patients with excellent results, however Government exemptions are required for the ongoing import of the device in Russia. This is a slow and tedious process in getting approval, therefore CELZ progress has been delayed in Russia.
Your DD will show that Dr. Gershman has been performing the procedure with EXCELLENT results…Up to 90% success rate, even in difficult patients. CELZ has received positive feedback from treating physicians of a 70% to 90% efficacy in their patients. Obviously results differ depending on the age and health of the patient and cause and severity of their erectile dysfunction.
A one-year trial has concluded and will PROVE the same results and you can watch it here; https://clinicaltrials.gov/ct2/show/NCT03699943...
CELZ is working on their paper for publication. This is ongoing and in compliance with contractual obligations. Once the paper has been approved by The Journal of Translational Medicine and a publication date advised, shareholders will be updated. Additionally, CELZ has designed an electronic patient registry that is intended to include data from the clinical trial, data from treating physicians using centrifuge technology with a 30cc to 60cc bone marrow aspiration and the second generation, needle only.
Revenue has now started, CELZ is cash flowing. Additional physicians are scheduled for training, patients are being treated and revenues are being generated and increasing each month. CELZ anticipates reaching financial self-sufficiency by revenues from sales in 2019.
CELZ has Institutional Investors now, slowing dilution and providing much better terms as CELZ completes the commercialization phase. The most recent notes that were issued in 2018 were renegotiated providing cash for operations.
CELZ signed with PatientGain to redesigning the website for the anticipated HUGE volume of traffic CaverStem® and FemCelz will generate. This has generated many calls to the vetted doctors.
CMTH anticipates acquiring the Virility Centers of America brand from affiliate company Creative Medical Health, Inc. The use of the Virility Centers brand is related to male and female wellness clinics, including sexual function (CaverStem® and FemCelzTM), incontinence and infertility. This brand will compliment the CaverStem® and FemCelz brands.
CaverStem® and FemCelz are just TWO of SEVERAL patents held by CMTH.
4 NEW patents were applied for in 2018.
Gershman and Ichim have already successfully commercialized Medistem.
CaverStem®, FemCelz, StemSpine & AmnioStem have all be TRADEMARKED
CaverStem is now a REGISTERED TRADEMARK. Caverstem®
We KNOW Caverstem® + FemCelz + StemSpine + AmnioStem = NASDAQ
This is all that matters.......but don't trust me or anyone on the blog. Do you own DD please. The FDA does not regulate medical procedures performed by qualified and licensed doctors. CaverStem has the only clinically proven procedure to treat Erectile Dysfunction with adult stem cells in the US. CaverStem ONLY uses your own adult stem cells (not Embryonic stem cells) and they are not altered, manipulated or stored. Therefore, FDA does not object to these procedures. CaverStem has been shown to be effective even in patients who do not respond to PDE5 inhibitors. CaverStem is safe. Several doctors in the US have been vetted and signed and are now OPEN and treating patients (Doctors Gershman, Said, Bieri, Liu, Narayan, Niemczyk and Sanderson). Currently you can make an appointment any of those locations along with Dr. Antonini in Rome, Italy. CELZ added physicians in Hawaii (Sanderson), California, Ohio, Texas and Tennessee (to be named soon) and CELZ will continually add the new physicians to the CaverStem™ website as they come aboard. To speed up new physician training due to demand, CELZ added additional medical personnel to travel to each physicians office to train. Due to the increased international demand and to compliment the existing relationship with Scott Shea, Thomas Bianchi has joined the company as the international sales representative. Over 50 domain names have been registered showing that MANY more doctors are being vetted or have shown interest. These includes MANY cities and states in the USA, and now we KNOW there are domains registered in Russia (PromoMed, Dr. Pushkar), Germany, France, Switzerland (Alto Uro, Dr. Bachmann) and Austria. CaverStem has begun a series of mailer and email campaigns introducing the CaverStem procedure to licensed physicians in the areas of urology, sexual function and plastic surgery. This campaign which will be expanded on a monthly basis with follow up mailers and emails and calls from our sales representatives. It's the goal to reach out to a minimum of 2500 new physicians each month by these methods. CaverStem reported good replies from the January emails. CaverStem has also increased its online presence on Social Media and by placing banner advertising on websites and search engines attracting the active male. They are currently scripting television commercials which will be edited to direct patients to each physician in their area. U.S. and international agreements have been reached for exclusive distribution rights for the FDA approved Generation 2 bone marrow harvest technology which has been used with multiple ED patients with excellent results, however Government exemptions are required for the ongoing import of the device in Russia. This is a slow and tedious process in getting approval, therefore CELZ progress has been delayed in Russia. Your DD will show that Dr. Gershman has been performing the procedure with EXCELLENT results…Up to 90% success rate, even in difficult patients. CELZ has received positive feedback from treating physicians of a 70% to 90% efficacy in their patients. Obviously results differ depending on the age and health of the patient and cause and severity of their erectile dysfunction. A one-year trial has concluded and will PROVE the same results and you can watch it here; https://clinicaltrials.gov/ct2/show/NCT03699943?recrs=deghi&fund=2&lupd_s=09%2F27%2F2018&lupd_d=14 Please review this. CELZ is working on their paper for publication. This is ongoing and in compliance with contractual obligations. Once the paper has been approved by The Journal of Translational Medicine and a publication date advised, shareholders will be updated. Additionally, CELZ has designed an electronic patient registry that is intended to include data from the clinical trial, data from treating physicians using centrifuge technology with a 30cc to 60cc bone marrow aspiration and the second generation, needle only. Revenue has now started, CMTH is cash flowing. Additional physicians are scheduled for training, patients are being treated and revenues are being generated and increasing each month. CMTH anticipates reaching financial self-sufficiency by revenues from sales in 2019. CMTH has Institutional Investors now, slowing dilution and providing much better terms as CMTH completes the commercialization phase. The most recent notes that were issued in 2018 were renegotiated providing cash for operations. CaverStem signed with PatientGain to redesigning the website for the anticipated HUGE volume of traffic CaverStem will generate. This has generated many calls to the vetted doctors. CMTH has started commercializing and scheduling patients for the FemCelz procedure for the treatment of female sexual dysfunction using stem cells from the patient's own bone marrow. Many of the existing CaverStem affiliated physician's will also treat female patients for sexual function and we anticipate that they will be the leaders in progressing the FemCelz program. CMTH anticipates acquiring the Virility Centers of America brand from affiliate company Creative Medical Health, Inc. The use of the Virility Centers brand is related to male and female wellness clinics, including sexual function (CaverStemTM and FemCelzTM), incontinence and infertility. This brand will compliment the CaverStem and FemCelz brands. CaverStem and FemCelz are just TWO of SEVERAL patents held by CMTH. 4 NEW patents were applied for in 2018. Gershman and Ichim have already successfully commercialized Medistem. CaverStem, FemCelz, StemSpine & AmnioStem have all be TRADEMARKED CaverStem is now a REGISTERED TRADEMARK. Caverstem® We KNOW Caverstem® + FemCelz + StemSpine + AmnioStem = NASDAQ PLEASE
This is all that matters.......but don't trust me or anyone on the blog. Do you own DD please. The FDA does not regulate medical procedures performed by qualified and licensed doctors. CaverStem has the only clinically proven procedure to treat Erectile Dysfunction with adult stem cells in the US. CaverStem ONLY uses your own adult stem cells (not Embryonic stem cells) and they are not altered, manipulated or stored. Therefore, FDA does not object to these procedures. CaverStem has been shown to be effective even in patients who do not respond to PDE5 inhibitors. CaverStem is safe. Several doctors in the US have been vetted and signed and are now OPEN and treating patients (Doctors Gershman, Said, Bieri, Liu, Narayan, Niemczyk and Sanderson). Currently you can make an appointment any of those locations along with Dr. Antonini in Rome, Italy. CELZ added physicians in Hawaii (Sanderson), California, Ohio, Texas and Tennessee (to be named soon) and CELZ will continually add the new physicians to the CaverStem™ website as they come aboard. To speed up new physician training due to demand, CELZ added additional medical personnel to travel to each physicians office to train. Due to the increased international demand and to compliment the existing relationship with Scott Shea, Thomas Bianchi has joined the company as the international sales representative. Over 50 domain names have been registered showing that MANY more doctors are being vetted or have shown interest. These includes MANY cities and states in the USA, and now we KNOW there are domains registered in Russia (PromoMed, Dr. Pushkar), Germany, France, Switzerland (Alto Uro, Dr. Bachmann) and Austria. CaverStem has begun a series of mailer and email campaigns introducing the CaverStem procedure to licensed physicians in the areas of urology, sexual function and plastic surgery. This campaign which will be expanded on a monthly basis with follow up mailers and emails and calls from our sales representatives. It's the goal to reach out to a minimum of 2500 new physicians each month by these methods. CaverStem reported good replies from the January emails. CaverStem has also increased its online presence on Social Media and by placing banner advertising on websites and search engines attracting the active male. They are currently scripting television commercials which will be edited to direct patients to each physician in their area. U.S. and international agreements have been reached for exclusive distribution rights for the FDA approved Generation 2 bone marrow harvest technology which has been used with multiple ED patients with excellent results, however Government exemptions are required for the ongoing import of the device in Russia. This is a slow and tedious process in getting approval, therefore CELZ progress has been delayed in Russia. Your DD will show that Dr. Gershman has been performing the procedure with EXCELLENT results…Up to 90% success rate, even in difficult patients. CELZ has received positive feedback from treating physicians of a 70% to 90% efficacy in their patients. Obviously results differ depending on the age and health of the patient and cause and severity of their erectile dysfunction. A one-year trial has concluded and will PROVE the same results and you can watch it here; https://clinicaltrials.gov/ct2/show/NCT03699943?recrs=deghi&fund=2&lupd_s=09%2F27%2F2018&lupd_d=14 Please review this. CELZ is working on their paper for publication. This is ongoing and in compliance with contractual obligations. Once the paper has been approved by The Journal of Translational Medicine and a publication date advised, shareholders will be updated. Additionally, CELZ has designed an electronic patient registry that is intended to include data from the clinical trial, data from treating physicians using centrifuge technology with a 30cc to 60cc bone marrow aspiration and the second generation, needle only. Revenue has now started, CMTH is cash flowing. Additional physicians are scheduled for training, patients are being treated and revenues are being generated and increasing each month. CMTH anticipates reaching financial self-sufficiency by revenues from sales in 2019. CMTH has Institutional Investors now, slowing dilution and providing much better terms as CMTH completes the commercialization phase. The most recent notes that were issued in 2018 were renegotiated providing cash for operations. CaverStem signed with PatientGain to redesigning the website for the anticipated HUGE volume of traffic CaverStem will generate. This has generated many calls to the vetted doctors. CMTH has started commercializing and scheduling patients for the FemCelz procedure for the treatment of female sexual dysfunction using stem cells from the patient's own bone marrow. Many of the existing CaverStem affiliated physician's will also treat female patients for sexual function and we anticipate that they will be the leaders in progressing the FemCelz program. CMTH anticipates acquiring the Virility Centers of America brand from affiliate company Creative Medical Health, Inc. The use of the Virility Centers brand is related to male and female wellness clinics, including sexual function (CaverStemTM and FemCelzTM), incontinence and infertility. This brand will compliment the CaverStem and FemCelz brands. CaverStem and FemCelz are just TWO of SEVERAL patents held by CMTH. 4 NEW patents were applied for in 2018. Gershman and Ichim have already successfully commercialized Medistem. CaverStem, FemCelz, StemSpine & AmnioStem have all be TRADEMARKED CaverStem is now a REGISTERED TRADEMARK. Caverstem® We KNOW Caverstem® + FemCelz + StemSpine + AmnioStem = NASDAQ PLEASE
Go CELZ!
I know the company. I have confidence in the company. Nothing here except getting $$$ by trading shares. Once everything is operational (more doctors vetted/trained) and other items (FemCelz) going like gang busters, we'll be okay.
Do what you want. Know what you have. Jump ship or stay the course. The choice is yours.
Know what you own. Work on what you know. Don't like it, LEAVE!
$CELZ
$CELZ Rocks!!!!
If you like it, buy it.
If you don't like it, don't buy it....GOOD BYE!
Oh Captain, My Captain!
Go $CELZ!!!!
There’s a company that started out with 350 million shares outstanding and had over 5 Billion available. The company raised its outstanding shares to 520 million, then 620, then 715, up to over 5 billion shares. They had many products in the “hopper” and one of them was going to make them millions. However, they needed financing to get the product to the market. Once that happened, the market took care of itself. The company continued to “dilute” shares all the way up to over 5.78 billion. You would think this pathetic company would face financial ruin, or go bankrupt. They didn’t. What they did was create a multi-million dollar company with dividends. The share price is $43+ today. How does it happen? Why can it happen? Confidence in the company. Confidence in the product. Confidence by the Shareholders. What is this company? Pfizer.
Can $CELZ be the next one? Who Knows. I have confidence. I’m not worried when they need capitol to get this train rolling and out of the station. I’m here for the long haul.
Still Long and not going anywhere!
GO CELZ!
Still here, still long. NOT GOING ANYWHERE!
Posse Signals are around, just nothing direct.
Three Institutional Investors. Why do you think they invested in this and wiped out ALL their debt? They didn't invest to lose all their money.
I just added too!
VACATION is over for some it seems. Welcome back to those that have been gone. CELZ is rockin' don't come a knockin'
I'm good here. I'm Long Here! NSX you're my hero here!
I'll see everyone in Vegas!
I agree! Here We Go!!!!
Thanks CF! I think I'm with a lot of Longs when I say I don't get what is going on. Dilution is one thing, but the fundamentals of the company are there. The Doctors signed up are there. The procedures are happening.
We're waiting on the Trial results, the next Q (which we all know will be good, but not over the top), and any other PRs.
Most of us are sitting tight, holding.....and expecting some good news to flip this stock up.
I have my shares locked up. The guys I brought in, and don't post, have their shares locked up too. It's just a matter of time.
Random thoughts:
When the PPS was $.07 at the end of June, we had around 545 milly shares in the mix. After Dilution, the shares went up to 784+ milly, now they’re at 806+ milly. Ask yourself, if the PPS was $.07 with 545 milly, that was $38,150,000 for OUR company. If nothing has changed but the number of shares, that should put our share price at $.047, but it is at $.014. Ask yourself Why? For me it is no problem. I have nothing but time and patience.
The company hasn’t changed. They didn’t lose Caverstem. They didn’t lose their patents. They’re working hard at making the company great. They need to start generating the revenue. I believe that is happening.
There wouldn’t be all of this interest in Caverstem if it didn’t work.
Good luck to longs!
Good Morning CELZrs! It's all about Patience and Time. The Longs have been here a while and the DD has been updated. We know what we own.
We're waiting for the Q, then 12/19, then the Q in February.
We all know the February Q will have Russia in it. This one won't. We also know this will show the 3 Investors along with revenue.
If you KNOW what you're doing, you will have the confidence we have. Average down on these low days. When the Price goes up to .05, .1, .2, you'll be stating, I wish I would have bought more back then.
Most of us have said it many times, know what you own and trust the DD. I'm happy with what is happening with the company. They do everything by the book.
My shares are locked and being held for however long it will take.
It's a GREAT thing to see!
Good Morning Everyone! Sorry I haven't posted in a while, but I got too busy with work. I'm still busy, still long and I'm not going anywhere. My shares are locked up too.
Good luck to everyone. Keep up the good work. We'll get to where want to be.
KNOW WHAT YOU OWN! BELIEVE WHO YOU BELIEVE.
IGNORE THE FUD!
Good Morning CELZ! Know what you own. Do your own DD and trust it.
Good luck to everyone!
THIS IS THE REASON WHY WE WENT THROUGH TOUGH TIMES LAST WEEK
Read NSX's post. If you don't think the shares were absorbed, then why did the price take a hit and come back up? It's factored in.
I feel bad for some with Weak Hands next week.
Have a great Labor Day Weekend!